BasketballNetwork.net on MSN

"It's not so much what you do… it's actually what you don't do" - Gary Vitti on how restraint shaped Kobe Bryant’s comeback

Gary Vitti shares insights on Kobe Bryant’s Achilles comeback journey.

FDA Approves Corcept’s Selective Glucocorticoid Receptor Antagonist Lifyorli™ (relacorilant) Plus Nab-Paclitaxel for Treatment of Patients with Platinum-Resistant Ovarian ...

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic ...